Academics file lawsuit over lung cancer vaccine IP; GAVI fundraising scheme nets $152M;

> Two University of Pittsburgh academics have filed a lawsuit over the rights to lung disease vaccine research. News

> GAVI has raised $152 million from a private sector donation matching scheme over the past 30 months. Item

> European health authorities have published their third risk assessment of the H7N9 virus. Report (PDF)

> Rhode Island is debating whether to make annual flu vaccinations mandatory for kids up to the age of 5. Piece

> Researchers at Duke University are developing a nasally-delivered West Nile virus vaccine. Release

> President Barack Obama singled out vaccines as a growth industry in the 2014 State of the Union address. Transcript

> Medigene has acquired dendritic cell vaccine assets in a buyout of Trianta Immunotherapies worth up to $13 million. Article

> Merck ($MRK) is set to begin supplying its shingles vaccine to New Zealand after years of shortages. News

> Australian researchers are advancing a whooping cough vaccine through preclinical testing. Piece

> The Dutch government has asked GlaxoSmithKline ($GSK) and Novartis ($NVS) to buy back swine flu vaccines. Item

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.